Nocturia Management

Introduction to Nocturia

• Nicotine consumption can exacerbate nocturia by disrupting sleep patterns and increasing urinary frequency, and management should focus on smoking cessation, behavioral modifications, and addressing underlying causes using the SCREeN approach, as recommended by the European Association of Urology 1

Evaluation and Assessment

• The European Association of Urology recommends using the SCREeN approach to evaluate nocturia, which includes performing baseline investigations: electrolytes, renal function, thyroid function, calcium, HbA1c, and urine dipstick 1
• A 72-hour bladder diary should be completed to confirm nocturnal polyuria and evaluate for underlying causes of nocturia using the SCREeN approach 1
• Nocturnal polyuria is defined as excessive nighttime urine production >33% of 24-hour volume, a key factor in diagnosing nocturia, according to the International Continence Society 1
• Global polyuria is defined as >2.5L urine production per 24 hours, and nocturia occurs through three main mechanisms, including increased urine production at night, decreased bladder storage capacity, and global polyuria 1
• Post-void residual measurement should be performed to assess for urinary retention in patients with Parkinson's disease 1
• Orthostatic hypotension, defined as a fall of 20 systolic or 10 diastolic within the first minute of standing, should be checked for in patients with Parkinson's disease 1

Behavioral Modifications

• Behavioral modifications, such as fluid management, sleep hygiene, evening diet, and medication timing adjustments, can help manage nocturia, as suggested by the European Association of Urology 1
• The American Urological Association and the European Urology association recommend beginning with lifestyle modifications, including:
• Administering a low dose of furosemide during the daytime, which can decrease nocturia by shifting urine production to daytime hours, particularly when timed 6 hours before sleep, as recommended by the European Urology guidelines 1
• The American Heart Association recommends restricting fluid intake in the evening, avoiding caffeine and alcohol, and elevating legs to mobilize fluid to reduce nocturia, with a strength of evidence level of B 2

Medication Review and Adjustment

• The European Association of Urology recommends reviewing and adjusting the timing of medications that may contribute to nocturia, including diuretics, antidepressants, antimuscarinics, antihistamines, and decongestants 1
• The European Urology guideline suggests reviewing and adjusting the timing of antiparkinsonian medications, considering morning dosing of medications that may increase urination, ensuring adequate dopaminergic coverage throughout the night, and considering the duration of drug effect relative to the patient's bedtime 1
• Reviewing the timing of diabetes medications, antiparkinsonian drugs, anxiolytics, antidepressants, antimuscarinics, antihistamines, and decongestants is essential to optimize treatment and reduce nocturia symptoms, as recommended by the European Urology association 1
• The American College of Cardiology recommends adjusting the timing of metformin to morning dosing to reduce nocturnal diuresis and improve sleep quality, considering the patient's symptoms and current medication regimen 2
• The American Diabetes Association suggests that metformin can cause or exacerbate neuropathy through B12 deficiency, and recommends monitoring vitamin B12 levels 2
• The National Institute of Neurological Disorders and Stroke indicates that statins, such as rosuvastatin, are associated with peripheral neuropathy, and recommends considering alternative lipid-lowering agents if symptoms persist 2
• The American Heart Association recommends considering a dose reduction of citalopram from 40mg to 20mg daily, as high doses can cause significant fatigue and QT prolongation, with a strength of evidence level of B 2
• The Endocrine Society recommends monitoring blood glucose levels if metformin timing is changed, as neuropathy and nocturia can be diabetes-related, with a strength of evidence level of A 2

Fall Prevention

• Fall prevention measures, such as ensuring a clear pathway to the bathroom, installing nightlights, considering a bedside commode, and assessing fracture risk using tools like FRAX, can help reduce the risk of falls in patients with nocturia, as recommended by the European Association of Urology 1
• Fracture risk should be assessed using tools like FRAX in patients with Parkinson's disease 1
• Fall prevention is crucial, especially in elderly patients, and may include:

Treatment and Follow-up

• The European Urology guideline suggests reassessing patients after 4-6 weeks of intervention and considering combination therapy or urological referral for urodynamic studies if nocturia persists despite treatment 1
• Desmopressin therapy may be considered if nocturnal polyuria is confirmed (>33% of 24-hour urine volume at night), with monitoring of serum sodium at 7 days and 1 month after initiation, as suggested by the European Urology guidelines 1
• Providing patients with realistic expectations about therapy outcomes is recommended 1
• The American College of Cardiology recommends assessing response to metformin timing change for nocturia and monitoring for any adverse effects from medication adjustments in the short-term (2-4 weeks), with a strength of evidence level of B 2